(+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
|
|
|
- CAS-Nr.
- 151907-80-1
- Englisch Name:
- (+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
- Synonyma:
- Boc-L-PEC;BOC-L-ACPEC;Peramivir impurities9;(+)-(1R,4S)-Boc-g-Homocycloleu-2-ene;(+)-(1R,4S)-Boc-g-Homocycloleu-2-ene;(+)-(1R,4S)-N-Boc-g-homocycloleu-2-ene;(+)-(1R,4S)-N-BOC-GAMMA-HOMOCYCLOLEU-2-ENE;(1R,4S)-Boc-4-aminocyclopent-2-ene-carboxylic acid;(1R,4S)-4-Boc-aMino-cyclopent-2-enecarboxylic acid;(1R,4S)-4-(Boc-amino)-2-cyclopentenecarboxylic Acid
- CBNumber:
- CB5723368
- Summenformel:
- C11H17NO4
- Molgewicht:
- 227.26
- MOL-Datei:
- 151907-80-1.mol
|
(+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID Eigenschaften
- Schmelzpunkt:
- 152°C
- Siedepunkt:
- 382.3±42.0 °C(Predicted)
- Dichte
- 1.18
- storage temp.
- 2-8°C
- pka
- 4.31±0.40(Predicted)
- Aggregatzustand
- Crystalline Powder
- Farbe
- Off-white
- Optische Aktivit?t
- [α]20/D +48.5±2°, c = 1% in methanol
- BRN
- 6177417
- InChIKey
- WOUNTSATDZJBLP-JGVFFNPUSA-N
(+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
S-S?tze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
Chemische Eigenschaften
off-white crystalline powder
(+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 153)Lieferanten
- (1R,4S)-(+)-4-(BOC-AMINO)-2-CYCLOPENTENE-1-CARBOXYLIC ACID
- (+)-(1R,4S)-N-T-BUTOXYCARBONYL-1-AMINOCYCLOPENT-2-ENE-4-CARBOXYLIC ACID
- (1R,4S)-(-)-4-AMINOCYCLOPENT-2-ENE-1-CARBOXYLIC ACID, N-BOC PROTECTED
- (1R,4S)-(-)-4-(TERT-BUTOXYCARBONYL)AMINOCYCLOPENT-2-ENE-1-CARBOXYLIC ACID
- (+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENE-4-CARBOXYLIC ACID
- (+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
- (+)-(1R,4S)-N-BOC-GAMMA-HOMOCYCLOLEU-2-ENE
- (+)-(1S,4R)-N-BOC-1-AMINOCYCLOPENT-2-ENE-4-CARBOXYLIC ACID
- (1S,4R)-N-BOC-1-AMINOCYCLOPENT-2-ENE-4-CARBOXYLIC ACID
- (1S,4R)-N-TERT-BUTOXYCARBONYL-1-AMINO-2-CYCLOPENTENE-4-CARBOXYLIC ACID
- (1R,4S)-(+)-4-(BOC-AMINO)-2-CYCLOPENTENE -1-CARBOXYLIC ACID 98+%
- (+)-(1R,4S)-N-Boc-g-homocycloleu-2-ene
- (1S,4R)-N-BOC-1-Aminocyclopent-2-ene-4-carboxylic acid, 98% ee
- (1R,4S)-Boc-4-aminocyclopent-2-ene-carboxylic acid
- (1R,4S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-cyclopentene-1-carboxylic acid
- (1R,4S)-4-Boc-aMino-cyclopent-2-enecarboxylic acid
- (+)-(1R,4S)-N-Butoxycarbonyl-4-aMinocyclopent-2-enecarboxylic acid
- BOC-L-ACPEC
- (1R,4S)-(+)-4-(Boc-aMino)-2-cyclopentene-1-carboxylic acid
- Cis-(1R,4S)-4-Boc-aMino-2-Cyclopentene-1-carboxylic acid
- (1R,4S)-4-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-1-cyclopent-2-enecarboxylic acid
- cis-N-tert-Butoxycarbonyl-4-aminocyclopent-2-ene-1-carboxylic acid
- (+)-(1R,4S)-N-(Tert-Butoxy)Carbonyl 4-Aminocyclopent-2-enecarboxylic acid
- (+)-(1R,4S)-Boc-g-Homocycloleu-2-ene
- (1R,4S)-4-{[(2,2-dimethylpropanoyl)oxy]amino}cyclopent-2-ene-1-carboxylic acid
- (1R,4S)-4-tert-Boc-amino-cyclopent-2-enecarboxylic acid
- 4S)-(+)-4-(BOC-AMINO)-2-CYCLOPENTENE-1-CARBOXYLIC ACID
- 4S)-N-T-BUTOXYCARBONYL-1-AMINOCYCLOPENT-2-ENE-4-CARBOXYLIC ACID
- Boc-L-PEC
- 2-Cyclopentene-1-carboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, (1R,4S)-
- (1S,4R)-N-BOC-1-Aminocyclopent-2-ene-4-carboxylicaci
- (+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID USP/EP/BP
- (+)-(1R,4S)-4-[(t-Butoxycarbonyl)amino]cyclopent-2-ene-1-carboxylic acid
- Peramivir impurities9
- (+)-(1R,4S)-Boc-g-Homocycloleu-2-ene
- (+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
- (1R,4S)-4-(Boc-amino)-2-cyclopentenecarboxylic Acid
- (1R,4S)-4-(Boc-amino)cyclopent-2-ene-1-carboxylic acid
- 151907-80-1
- Alicyclic Amino Acids
- Peptide Synthesis
- Specialty Synthesis
- Unnatural Amino Acid Derivatives
- Unusual amino acids
- Alicyclic Amino Acids
- Peptide Synthesis
- Unnatural Amino Acid Derivatives
